| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/07/2008 | US20080187646 Increase in Yield by Reducing Gene Expression |
| 08/07/2008 | US20080187551 Nucleotide sequences coding oncogenic polypeptides for use in generating vaccines to prevent and treat cell proliferative disorders; genetic vaccines |
| 08/07/2008 | US20080187548 Ny-Eso-1 Peptides Which Bind To Class II Molecules And Uses Thereof |
| 08/07/2008 | US20080187547 Immune receptor translocation associated-5 (IRTA-5 ) protein specific immunoglobulin for use in diagnosis, prevention and treatment of B cell malignancies |
| 08/07/2008 | US20080187545 Cytomegalovirus surface protein complex for use in vaccines and as a drug target |
| 08/07/2008 | US20080187541 Helicobacter pylori adhesin binding group antigen |
| 08/07/2008 | US20080187540 Osteoclastogenesis inhibitory factor-binding molecule (OBM) specific immunoglobulin for use inhibiting osteoclast inhibitory factor (OCIF) binding activity and treating bone disorders |
| 08/07/2008 | US20080187539 Chemokine receptor specific monoclonal antibody for prevention and treatment of human immunodeficiency infection |
| 08/07/2008 | US20080187538 Posh nucleic acids, polypeptides and related methods |
| 08/07/2008 | US20080187537 Using immunodeficient animals to generate cancer cell infiltrating lymphocytes; immunotherapy; tissue targeted therapy |
| 08/07/2008 | US20080187535 Vaccine |
| 08/07/2008 | US20080187534 Anti-vegf antibodies |
| 08/07/2008 | US20080187533 Treatment with anti-erbb2 antibodies |
| 08/07/2008 | US20080187532 Compositions and methods for diagnosing and treating cancer |
| 08/07/2008 | US20080187531 Antibodies directed to tumor necrosis factor and uses thereof |
| 08/07/2008 | US20080187530 Novel Agents and Use Thereof |
| 08/07/2008 | US20080187529 Anti-human vegf receptor flt-1 monoclonal antibody |
| 08/07/2008 | US20080187528 Anti-tsg101 antibodies and their uses for treatment of viral infections |
| 08/07/2008 | US20080187527 Novel endometriosis-associated gene |
| 08/07/2008 | US20080187520 Expression vector comprising nucleotide sequences coding cytotoxic exoenzyme fusion for use as tool in development of vaccine which prevent pseudomonal infection; genetic vaccines |
| 08/07/2008 | US20080187488 Phage antibodies to radiation-inducible neoantigens |
| 08/07/2008 | US20080187461 Protein, method for immobilizing protein, structure, biosensor, nucleic acid, vector and kit for detecting target substance |
| 08/07/2008 | DE102007005804A1 Sekretierte Luziferase Lu164M3 und deren Verwendung Secreted Luciferase Lu164M3 and their use |
| 08/07/2008 | DE102007005803A1 Sekretierte Luziferase MLuc7 und deren Verwendung Secreted Luciferase MLuc7 and their use |
| 08/07/2008 | CA2677207A1 Compositions and methods for detecting cancers in a subject |
| 08/07/2008 | CA2677175A1 Sub-population of hematopoietic stem cells that express the crisp-1 protein |
| 08/07/2008 | CA2677163A1 Humanized antibodies against cxcr3 |
| 08/07/2008 | CA2676838A1 Allergen-binding ige monoclonal antibodies and method for preparing hypoallergens |
| 08/07/2008 | CA2674721A1 Enzymes for the treatment of lignocellulosics, nucleic acids encoding them and methods for making and using them |
| 08/07/2008 | CA2655903A1 Ilt3 binding molecules and uses therefor |
| 08/07/2008 | CA2651866A1 Sialoadhesin-related compositions and methods |
| 08/06/2008 | EP1953551A2 Prion protein ligands and methods of use |
| 08/06/2008 | EP1953243A2 Polynucleotides related to colon cancer |
| 08/06/2008 | EP1953235A2 New genes related to a process for the production of fine chemicals |
| 08/06/2008 | EP1953229A2 Metastatic breast and colon cancer regulated genes |
| 08/06/2008 | EP1953226A1 Membrane molecule expressed specifically in activated plasmacytoid dendritic cell |
| 08/06/2008 | EP1953173A1 Secreted and transmembrane polypeptides and nucleic acids endoding the same |
| 08/06/2008 | EP1951910A2 Identification of genetic polymorphic variants associated with somatosensory disorders and methods of using the same |
| 08/06/2008 | EP1951902A1 Methods and compositions for the assessment of cardiovascular function and disorders |
| 08/06/2008 | EP1951891A1 Cancer antigen mage-a9 and uses thereof |
| 08/06/2008 | EP1951760A2 Human monoclonal antibody human cd134 (ox40) and methods of making and using same |
| 08/06/2008 | EP1951759A2 Anti-egfr antibodies |
| 08/06/2008 | EP1951758A2 Neuropilin antagonists |
| 08/06/2008 | EP1951757A2 Optimized anti-cd30 antibodies |
| 08/06/2008 | EP1951756A2 Anti-myostatin antibodies |
| 08/06/2008 | EP1951755A2 Anti-myostatin antibodies |
| 08/06/2008 | EP1951754A2 Antibody polypeptide library screening and selected antibody polypeptides |
| 08/06/2008 | EP1951749A2 Methods of using phhla2 to co-stimulate t-cells |
| 08/06/2008 | EP1951748A2 Hepatitis c virus variants |
| 08/06/2008 | EP1951304A1 Method for treating joint damage |
| 08/06/2008 | EP1585546B1 Kim-1 antagonists and use to modulate immune system |
| 08/06/2008 | EP1498487B1 35 kd protein |
| 08/06/2008 | EP1485718B1 Method for monitoring collagen type ii degradation in cartilage |
| 08/06/2008 | EP1478777B1 Genetic marker for diffentiating mycobacteria |
| 08/06/2008 | EP1455824B1 Lyophilized preparation containing antibodies to the egf receptor |
| 08/06/2008 | EP1350521B1 Immunotherapeutic combinations for the treatment of tumors |
| 08/06/2008 | EP1237575B1 Tnf-alpha antagonist and lfa-1 antagonist for treating rheumatoid arthritis |
| 08/06/2008 | EP1157042B1 Production of tetravalent antibodies |
| 08/06/2008 | EP1108034B1 Attenuated salmonella spi2 mutants as antigen carriers |
| 08/06/2008 | EP0938548B1 Isolated tumor necrosis factor receptor releasing enzyme, compositions comprising the enzyme and methods of the use thereof |
| 08/06/2008 | EP0832109B1 Fibroblast growth factor homologous factor-2 and methods of use |
| 08/06/2008 | EP0722336B1 Recombinant coffee bean alpha-galactosidase |
| 08/06/2008 | EP0666911B9 Multidrug resistance gene |
| 08/06/2008 | CN101238150A Recombinant method for the production of a monoclonal antibody to CD52 for the treatment of chronic lymphocytic leukemia |
| 08/06/2008 | CN101238149A Novel anti-IGF-IR antibodies and uses thereof |
| 08/06/2008 | CN101238148A Method of producing antibodies with modified fucosylation level |
| 08/06/2008 | CN101237881A Immunoconjugate formulations |
| 08/06/2008 | CN101235089A Anti-beta2GPI gene engineering Fab antibody |
| 08/06/2008 | CN101235088A Preparation of anti-human seminoprotein specificity single chain antibody and application method thereof |
| 08/06/2008 | CN101235087A Method for preparing LKB1 gene Thr336 phosphoric acid polyclonal antibody and application thereof in detecting tumor generation |
| 08/06/2008 | CN101235086A Recombination human rabies viruses resisting antibody |
| 08/06/2008 | CN101235085A Monoclonal antibody of membrane protein E for resisting West Nile virus and application thereof |
| 08/06/2008 | CN101235083A HIV-I resisting polypeptide, coded sequence and use thereof |
| 08/06/2008 | CN100408687C Nucleic acid molecules from rice and their use for the prodn. of modified starch |
| 08/06/2008 | CN100408684C Method for detecting or determining HCV core antigen and reagent for detecting and determining used thereof |
| 08/06/2008 | CN100408683C HLA-A24-restricted cancer antigen peptide |
| 08/06/2008 | CN100408597C Human calcium ion / calmodulin deopendent protein kinase II inhibitory protein alpha, its coded sequence and use |
| 08/06/2008 | CN100408097C Double specific ERB-B antibody and its use in treating tumor |
| 08/05/2008 | US7408100 Method of controlling character of monocotyledon by modification and/or overexpression of cytochrome P450 monooxygenase gene involved in brassinosteroid biosynthesis and monocotyledon modified by the gene |
| 08/05/2008 | US7408043 Neutralizing antibody against HGF |
| 08/05/2008 | US7408042 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis |
| 08/05/2008 | US7408041 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 08/05/2008 | US7408040 Antibodies to PDGF-D |
| 08/05/2008 | US7408039 Induction of chimera mixture; anticancer agents, leukemia |
| 08/05/2008 | US7408036 Human voltage gated sodium channel β1A subunit and methods of use |
| 08/05/2008 | US7408034 PRO20025 polypeptides |
| 08/05/2008 | US7408033 PRO5995 polypeptides |
| 08/05/2008 | US7408032 PRO polypeptides; fused to heterologous polypeptide sequences |
| 08/05/2008 | US7408027 Epitopes of the tau protein which are specifically occurring in a phosphorylated state in tau protein from Alzheimer paired helical filaments; for the generation of antibodies specifically detecting Alzheimer tau protein; for testing drugs effective in dissolving Alzheimer paired helical filaments |
| 08/05/2008 | US7407935 Ricin toxin A-chain fragment for use as a vaccine |
| 08/05/2008 | US7407792 Compositions, organisms and methodologies employing a novel human kinase |
| 08/05/2008 | US7407753 Methods, kits and pharmaceutical compositions for diagnosing, delaying onset of, preventing and/or treating osteoporosis |
| 08/05/2008 | US7407751 Methods for the detection and prognosis of breast tumors |
| 08/05/2008 | US7407677 Nucleotide sequences coding hydrolases for use in cleaning agents, detergents, textile treatment, baking, inking recycled paper, animal feeds, beverages and in the oilfield industry |
| 08/05/2008 | US7407659 Methods of diagnosing pre-eclampsia or eclampsia |
| 08/05/2008 | US7407656 PSCA: prostate stem cell antigen and uses thereof |
| 08/05/2008 | US7407475 Modified annexin proteins, and methods and compositions for using them |
| 08/05/2008 | CA2340888C Novel tumor antigen protein sart-3 and tumor antigen peptide thereof |
| 08/05/2008 | CA2290485C Method for the production of non-immunogenic proteins |
| 08/05/2008 | CA2246715C Antibody variants |